Overall, the immune composition analysis suggests that HPV+ tumors are more immunogenic than HPV− tumors and that CD8 T-cell and B-cell abundance accounts for better survival in HPV+ HNSCC. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.